1. Atherosclerosis: inhibition or regression as therapeutic possibilities
- Author
-
Davies, M.J., Krikler, D.M., and Katz, D.
- Subjects
Atherosclerosis -- Models ,Atherosclerosis -- Physiological aspects ,Cholesterol -- Physiological aspects ,Health - Abstract
Atherosclerosis, or hardening of the arteries, is caused by the buildup of lipids (fats) and connective tissues inside the walls of the arteries. This complex mechanism of plaque formation is described. The resulting lesions are difficult to measure, complicating treatment evaluation. Angiography, X-ray imaging of the arteries, is of limited value in detecting plaques, and is not well suited to calculating the extent of atherosclerosis, although computerized image analysis now provides more objective measures. Clinical end points, such as fatal and nonfatal heart attack or unstable angina (pain from reduced blood flow to the heart), or other deaths related to the heart can also be used to measure the effectiveness of treatment. Regression and prevention of atherosclerosis in studies of animals and humans are discussed. In humans, atherosclerotic plaques contain collagen (connective tissue), calcium and lipids, and often relatively little lipid is present. If humans are similar to animal models, lipids are removed quickly, but collagen is removed slowly, suggesting that treatment to reduce these lesions must be very slow. However, new lesions may be prevented and lesions containing greater amounts of lipids may respond to treatment. Data are required on both the severity of disease and on the rate of complications from atherosclerosis to determine the effectiveness of treatment. Several trials of treatments for atherosclerosis are reviewed. (Consumer Summary produced by Reliance Medical Information, Inc.)
- Published
- 1991